Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Monday 10 December, 2012

Curanum Ag

EANS-Adhoc: Curanum AG examines takeover offer ...

PR Newswire/euro adhoc/
EANS-Adhoc: Curanum AG examines takeover offer from Korian Deutschland AG
ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc 
with the aim of a Europe-wide distribution. The issuer is solely responsible for
the content of this announcement.

Mergers - Acquisitions - Takeovers

Korian Deutschland AG, Mannheim, a company which is in the course of foundation
and which is to be a wholly-owned subsidiary of Korian S.A., a company based in
Paris, France, has today informed Curanum AG concerning its decision about
issuing a voluntary public takeover offer for all outstanding Curanum shares,
and has announced this decision publicly in advance. The takeover offer includes
a minimum acceptance threshold of 75% on the basis of a price of EUR 2,5 per
Curanum share, according to information provided by Korian. 
This announcement was preceded by confidential discussions with the Management
Board of Curanum concerning a potential merging of the German business
activities of the Korian Group with Curanum. The Management and Supervisory
boards of Curanum AG envisage that such a transaction would basically make sense
from a strategic perspective for both its employees and the company since both
groups' activities and their respective regional coverage would complement each
other beneficially. 
Korian intends to submit its offer document to the German Federal Financial
Supervisory Authority (BaFin) within the next four weeks in line with the
provisions of the German Securities Takeover Act (WpÜG). Once the offer details
have been published, the Management and Supervisory boards will review such
details carefully before issuing a reasoned, public opinion on the offer,
especially with respect to the price offered. 

Munich, December 10, 2012,
The Management Board

Further inquiry note:
Caroline Lutz
Leitung Unternehmensentwicklung
Tel.: +49(0)89/ 24 20 65-0
E-Mail: [email protected]

issuer:      CURANUM AG
             Engelbertstraße 23-25
             D-81241 München
phone:       +49 (0)89 242065 0
FAX:         +49 (0) 89 242065 10
mail:        [email protected]
sector:      Healthcare Providers
ISIN:        DE0005240709
indexes:     CDAX, Classic All Share, Prime All Share
stockmarkets: free trade: Berlin, Hamburg, Düsseldorf, Stuttgart, regulated
             dealing: München, regulated dealing/prime standard: Frankfurt 
language:   English
The content and accuracy of news releases published on this site and/or 
distributed by PR Newswire or its partners are the sole responsibility of the 
originating company or organisation. Whilst every effort is made to ensure the 
accuracy of our services, such releases are not actively monitored or reviewed 
by PR Newswire or its partners and under no circumstances shall PR Newswire or 
its partners be liable for any loss or damage resulting from the use of such 
information. All information should be checked prior to publication.

a d v e r t i s e m e n t